Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kubicek

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Diagnostic Pathology|March 19, 2013
A gene expression profile test to resolve head & neck squamous versus lung squamous cancersAnita Lal, Rebecca Panos, Mira Marjanovic, et al.
International Journal of Radiation Oncology, Biology, Physics|December 17, 2008
Phase I trial using proteasome inhibitor bortezomib and concurrent temozolomide and radiotherapy for central nervous system malignanciesGregory J Kubicek, Maria Werner-Wasik, Mitchell Machtay, et al.
The Laryngoscope|October 15, 2013
Adjuvant stereotactic body radiotherapy±cetuximab following salvage surgery in previously irradiated head and neck cancerJohn A Vargo, Gregory J Kubicek, Robert L Ferris, et al.
Journal of Radiosurgery and SBRT|April 20, 2026
Inter-fraction monitoring of brain metastases resection cavities during fractionated stereotactic radiosurgery on the 0.35 T MRI-LinacNatalia Lutsik, Karen Chin Snyder, Eyub Y Akdemir, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 9, 2012
Prospective evaluation of patient-reported quality-of-life outcomes following SBRT ± cetuximab for locally-recurrent, previously-irradiated head and neck cancerJohn A Vargo, Dwight E Heron, Robert L Ferris, et al.
International Journal of Radiation Oncology, Biology, Physics|April 27, 2016
Stereotactic Radiosurgery for Poor Performance Status PatientsGregory J Kubicek, Alan Turtz, Jinyu Xue, et al.
Biomed Research International|September 4, 2013
Stereotactic body radiotherapy as an alternative to brachytherapy in gynecologic cancerGregory J Kubicek, Jinyu Xue, Qianyi Xu, et al.
International Journal of Radiation Oncology, Biology, Physics|January 17, 2012
Phase I trial using the proteasome inhibitor bortezomib and concurrent chemoradiotherapy for head-and-neck malignanciesGregory J Kubicek, Rita S Axelrod, Mitchell Machtay, et al.
Head & Neck|November 15, 2011
Stereotactic body radiation therapy for locally recurrent, previously irradiated nonsquamous cell cancers of the head and neckJohn A Vargo, Rodney E Wegner, Dwight E Heron, et al.
Head & Neck Oncology|April 21, 2012
A retrospective, deformable registration analysis of the impact of PET-CT planning on patterns of failure in stereotactic body radiation therapy for recurrent head and neck cancerKyle Wang, Dwight E Heron, John C Flickinger, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Diagnostic Pathology|March 19, 2013
A gene expression profile test to resolve head & neck squamous versus lung squamous cancersAnita Lal, Rebecca Panos, Mira Marjanovic, et al.
International Journal of Radiation Oncology, Biology, Physics|December 17, 2008
Phase I trial using proteasome inhibitor bortezomib and concurrent temozolomide and radiotherapy for central nervous system malignanciesGregory J Kubicek, Maria Werner-Wasik, Mitchell Machtay, et al.
The Laryngoscope|October 15, 2013
Adjuvant stereotactic body radiotherapy±cetuximab following salvage surgery in previously irradiated head and neck cancerJohn A Vargo, Gregory J Kubicek, Robert L Ferris, et al.
Journal of Radiosurgery and SBRT|April 20, 2026
Inter-fraction monitoring of brain metastases resection cavities during fractionated stereotactic radiosurgery on the 0.35 T MRI-LinacNatalia Lutsik, Karen Chin Snyder, Eyub Y Akdemir, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 9, 2012
Prospective evaluation of patient-reported quality-of-life outcomes following SBRT ± cetuximab for locally-recurrent, previously-irradiated head and neck cancerJohn A Vargo, Dwight E Heron, Robert L Ferris, et al.
International Journal of Radiation Oncology, Biology, Physics|April 27, 2016
Stereotactic Radiosurgery for Poor Performance Status PatientsGregory J Kubicek, Alan Turtz, Jinyu Xue, et al.
Biomed Research International|September 4, 2013
Stereotactic body radiotherapy as an alternative to brachytherapy in gynecologic cancerGregory J Kubicek, Jinyu Xue, Qianyi Xu, et al.
International Journal of Radiation Oncology, Biology, Physics|January 17, 2012
Phase I trial using the proteasome inhibitor bortezomib and concurrent chemoradiotherapy for head-and-neck malignanciesGregory J Kubicek, Rita S Axelrod, Mitchell Machtay, et al.
Head & Neck|November 15, 2011
Stereotactic body radiation therapy for locally recurrent, previously irradiated nonsquamous cell cancers of the head and neckJohn A Vargo, Rodney E Wegner, Dwight E Heron, et al.
Head & Neck Oncology|April 21, 2012
A retrospective, deformable registration analysis of the impact of PET-CT planning on patterns of failure in stereotactic body radiation therapy for recurrent head and neck cancerKyle Wang, Dwight E Heron, John C Flickinger, et al.
Pageof 6